Search Results 1901-1910 of 16137 for Epilepsy (Partial Onset)

  1. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Mayo Clinic

    The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit ...

  2. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

    About this study. This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta ...

  3. Publications - Gregory A. Broderick, M.D. - Mayo Clinic

    Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl Urol. 2016 Dec; 5 (6):824-833. View PubMed; Whitaker DA Jr ...

  4. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) - Mayo Clinic

    About this study. The purpose of this study is to compare the effectiveness and safety of unesbulin plus dacarbazine versus placebo plus dacarbazine in ...

  5. Emergency Medicine - Conditions treated - Mayo Clinic

    Fractures; Motor vehicle crash injuries; Head or neck injuries; Sudden severe headaches, paralysis, seizure or stroke symptoms; Dehydration. Mayo ...

  6. Funding - Aspirin-Exacerbated Respiratory Disease: Elina Jerschow - Mayo Clinic Research

    Investigator & Role, Grant Title, Funding Source, Duration. Elina Jerschow, M.D., M.S., principal investigator; Douglas G. Brownfield, Ph.D., co-principal ...

  7. Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - Mayo Clinic

    About this study. This phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin ...

  8. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... Activated partial thromboplastin (aPTT) and ... duration of study ...

  9. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of Type 3c diabeTes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis - Mayo Clinic

    New Onset Diabetes (< 9 years) in subjects with Chronic Pancreatitis;; New Onset Diabetes (<3 years) in subjects without Pancreatic disease (i.e., T2DM); ...

  10. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

    During the early phases (phases 1 and 2) ... focal RT ≥ 4 weeks prior to study entry. if the ... unless they commit to complete abstinence beginning ...